Literature DB >> 11162242

The endosomal trafficking of apolipoprotein E3 and E4 in cultured human brain neurons and astrocytes.

R M DeKroon1, P J Armati.   

Abstract

The association of the E4 isoform of apolipoprotein E (apoE) as a genetic risk factor for late onset Alzheimer's disease (AD) has been well established. Central nervous system (CNS) neurons are specifically affected so that defining the mechanisms by which two of the major human apoE isoforms act within CNS neurons is important to our understanding of their effect on neuronal maintenance and function. We have developed a cell culture model using human brain tissue to characterize exogenous apoE transport. We have tracked the association of apoE3 and E4 with CD63, the GTP-binding protein rab5a and the acidic hydrolase cathepsin D, which localize lysosomes, early endosomes, and late endosomes/lysosomes, respectively. Double immunostaining and confocal laser scanning microscopy revealed by z-series that after 30 min most intraneuronal apoE colocalized with rab5a, whereas no astrocyte apoE/rab5a colocalization was detected. Conversely, apoE3 and CD63 did not colocalize in neurons, even after 1 h, but was colocalized in astrocytes. Also, there was approximately 9% apoE3 colocalization with cathepsin D in neurons, whereas up to 87% of apoE4 vesicles were colocalized. In astrocytes, the proportion of apoE3 colocalized with cathepsin D was greater than that in neurons, but still significantly different from that found with apoE4. These immunohistological data demonstrate that, in neurons, apoE can be endocytosed via a rab5a-regulated vesicle-mediated pathway and that beyond this stage there may be isoform specific differences in apoE trafficking present in both neurons and astrocytes. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162242     DOI: 10.1006/nbdi.2000.0362

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  16 in total

1.  Following activation of the amyloid cascade, apolipoprotein E4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration.

Authors:  Haim Belinson; Zehavit Kariv-Inbal; Rakez Kayed; Eliezer Masliah; Daniel M Michaelson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD.

Authors:  Xuesong Chen; Liang Hui; Mahmoud L Soliman; Jonathan D Geiger
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014

3.  Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  Austin J Pharmacol Ther       Date:  2014-08-26

4.  Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts).

Authors:  Aristides D Tagalakis; J George Dickson; James S Owen; J Paul Simons
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis.

Authors:  E Schmukler; D M Michaelson; R Pinkas-Kramarski
Journal:  Mol Neurobiol       Date:  2018-01-20       Impact factor: 5.590

Review 6.  Progress toward identification of protease activity involved in proteolysis of apolipoprotein e in human brain.

Authors:  Marcos A Marques; Phillip A Owens; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

7.  Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Authors:  Marcos A Marques; Keith A Crutcher
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

8.  Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease.

Authors:  Xuesong Chen; Liang Hui; Jonathan D Geiger
Journal:  J Neurol Neurophysiol       Date:  2014-10-01

Review 9.  Endosomal Traffic Jams Represent a Pathogenic Hub and Therapeutic Target in Alzheimer's Disease.

Authors:  Scott A Small; Sabrina Simoes-Spassov; Richard Mayeux; Gregory A Petsko
Journal:  Trends Neurosci       Date:  2017-10       Impact factor: 13.837

10.  Endocytic pathway alterations in human hippocampus after global ischemia and the influence of APOE genotype.

Authors:  Barry W McColl; David I Graham; Christopher J Weir; Fiona White; Karen Horsburgh
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.